13F-HR filed by Deep Track Capital, LP
Deep Track Capital, LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 63 holding rows worth $2,590,824,056.
- Accession
- 0001856083-23-000005
- Filer
- CIK 1856083
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 63 entries on the cover page, a total value of $2,590,824,056 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,590,824,056 with VALUE read as dollars as filed, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INSMED INC COM PAR $.01 | 457669307 | Stock | 6,000,000 | $151,500,000 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 1,138,045 | $147,308,545 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 2,600,000 | $135,434,000 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 2,834,069 | $128,553,370 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 4,050,000 | $120,042,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 2,797,955 | $107,413,492 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 3,800,000 | $106,438,000 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 6,756,956 | $99,800,240 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,915,000 | $96,554,300 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 5,500,000 | $95,370,000 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 3,546,435 | $81,993,577 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,140,745 | $79,726,668 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 3,490,506 | $70,124,266 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 7,370,000 | $65,887,800 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 2,000,000 | $63,240,000 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 7,101,935 | $55,395,093 | dollars as filed | |
| GERON CORP | 374163103 | COM | 25,700,000 | $54,484,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 3,187,415 | $51,954,865 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 2,414,373 | $51,426,145 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 6,000,000 | $50,100,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,963,267 | $45,456,516 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 2,500,000 | $40,375,000 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 2,900,000 | $39,005,000 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 3,067,731 | $37,058,190 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 31,697,539 | $35,818,219 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 2,778,107 | $35,365,302 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 15,000,000 | $34,950,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 300,000 | $33,750,000 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 6,000,000 | $30,180,000 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,500,000 | $24,930,000 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,015,641 | $24,426,166 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 1,345,813 | $24,170,801 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,930,894 | $23,846,541 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 2,997,830 | $23,562,944 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 400,000 | $23,224,000 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,259,335 | $23,058,424 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 200,000 | $21,728,000 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,403,672 | $21,536,901 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 200,000 | $20,658,000 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,951,580 | $19,164,516 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 2,781,565 | $18,553,039 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 2,523,000 | $16,651,800 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P200 | ADR | 2,041,670 | $15,782,109 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,750,000 | $15,757,500 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 250,000 | $12,062,500 | dollars as filed | put |
| NEKTAR THERAPEUTICS | 640268108 | COM | 18,400,000 | $10,959,040 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 470,647 | $10,782,523 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 422,247 | $10,450,613 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 2,513,044 | $10,429,133 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 7,720,688 | $10,345,722 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 1,767,131 | $9,524,836 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 2,837,818 | $8,513,454 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,037,873 | $7,742,533 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 182,691 | $7,536,004 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 1,000,000 | $7,240,000 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 551,289 | $5,606,609 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 499,400 | $5,018,970 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 828,485 | $3,272,516 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 353,855 | $2,512,371 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 328,424 | $2,430,338 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 2,086,704 | $2,149,305 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 91,078 | $1,406,244 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 543,008 | $1,086,016 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001856083-23-000005 | this filing | 2023-11-14 | acceptance time not in the bulk data set |